Law Firm Examines Fairness of Clearwater Analytics Private Equity Acquisition

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Law firm investigates Clearwater Analytics' $24.55/share PE acquisition, questioning if price fairly values shareholders given prior analyst targets above $35.

Law Firm Examines Fairness of Clearwater Analytics Private Equity Acquisition

Kaskela Law LLC has initiated an investigation into the proposed acquisition of Clearwater Analytics Holdings, Inc. (NYSE: CWAN) by private equity funds at $24.55 per share. The investigation centers on whether the offer price adequately reflects fair value for shareholders, particularly given that sell-side analysts had previously maintained price targets in excess of $35 per share prior to the transaction announcement.

The significant gap between the acquisition price and recent analyst valuations has prompted the firm to assess whether the transaction terms are in the best interests of CWAN shareholders. The law firm is encouraging investors who hold stakes in the company to contact the firm to discuss potential claims related to the proposed buyout.

Kaskela Law LLC is simultaneously conducting investigations into other companies on behalf of shareholders, including BARK, Inc. and Marblegate Capital Corp., as part of its broader shareholder advocacy practice.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 13

Related Coverage

Benzinga

Mountain Commerce Bancorp Clears Regulatory Hurdles for Home BancShares Merger

Mountain Commerce Bancorp receives Federal Reserve and Arkansas regulatory approvals for merger with Home BancShares, expected to close in early Q2 2026.

HOMBMCBI
Benzinga

Smithfield Foods Surges on Robust Q4 Earnings, Nathan's Famous Deal

Smithfield Foods beat Q4 expectations with 83-cent EPS, announced $450M Nathan's Famous acquisition at $102/share, projecting $1.3-$1.5B FY26 operating profit. Stock surged 4.13%.

SFDNATH
Benzinga

Gilead Bolsters Inflammation Arsenal With $1.675B Ouro Medicines Deal

Gilead acquires Ouro Medicines for $1.675B upfront, targeting inflammation pipeline expansion. Galapagos NV partners to co-develop lead asset OM336.

GILDACLXGLPG
Benzinga

Vertiv Accelerates Capacity Push to Capitalize on AI Data Center Boom

Vertiv expands manufacturing capacity across three facilities and acquires ThermoKey to meet soaring AI data center demand for cooling and power infrastructure.

VRTAIPO
Benzinga

SEALSQ to Acquire Quantum Interconnect Firm Miraex in Strategic Stack Play

SEALSQ signs Letter of Intent to acquire Swiss quantum interconnect firm Miraex, completing its quantum technology stack and supporting space-based quantum infrastructure initiative.

LAESWKEY
Benzinga

VGTEL Eyes Health-Tech Acquisition From 4biddenknowledge in Strategic Bell Rose Deal

VGTEL enters formal discussions with Bell Rose Capital to acquire a pre-revenue health-tech app, with due diligence underway and potential advisory role for Bell Rose's president.

VGTLBELR